Facilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis

scientific article

Facilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0006-8993(93)90087-4
P698PubMed publication ID8252400

P2093author name stringTanaka M
Tanaka T
Yoshida M
Ishii H
Yokoo H
Mizoguchi K
Emoto H
P433issue1-2
P407language of work or nameEnglishQ1860
P921main subjectnicotineQ12144
opioidQ427523
P304page(s)277-280
P577publication date1993-10-01
P1433published inBrain ResearchQ4955782
P1476titleFacilitatory modulation of mesolimbic dopamine neuronal activity by a mu-opioid agonist and nicotine as examined with in vivo microdialysis
P478volume624

Reverse relations

cites work (P2860)
Q34201592A concept of welfare based on reward evaluating mechanisms in the brain: anticipatory behaviour as an indicator for the state of reward systems
Q38016946A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation
Q46880882Age differences in the spontaneous acquisition of nicotine self-administration in male Wistar and Long-Evans rats
Q44340810Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption.
Q29037482Effects of a secure attachment relationship on right brain development, affect regulation, and infant mental health
Q44352487Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors
Q33875395Functional brain imaging of tobacco use and dependence
Q33895975IP3 receptor sensitization during in vivo amphetamine experience enhances NMDA receptor plasticity in dopamine neurons of the ventral tegmental area
Q47962415Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release
Q73184561Ibogaine and the dopaminergic response to nicotine
Q34364830Identification of rat ventral tegmental area GABAergic neurons
Q33946922In vivo brain imaging of human exposure to nicotine and tobacco
Q73943268Interaction between alpha-MSH and acetylcholinergic system upon striatal cAMP and IP(3) levels
Q48595540Local muscimol disinhibits mesolimbic dopaminergic activity as examined by brain microdialysis and Fos immunohistochemistry
Q48131011Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats
Q44060471Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
Q48522936N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens
Q40867544Nicotine and endogenous opioids: toward specific pharmacotherapy
Q35903781Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner
Q40494298Role of the Nucleus Accumbens and the Striatum in the Production of Turning Behaviour in Intact Rats
Q37025119Selective breeding for high alcohol preference increases the sensitivity of the posterior VTA to the reinforcing effects of nicotine
Q48873657Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release
Q42451146The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis study in the rat brain
Q38338668Understanding opioid reward
Q33542009What peptides these deltorphins be.
Q37455456kappa-Opioid receptor signaling and brain reward function

Search more.